Global Acne Treatment Market

Acne Treatment Market Size, Share, Growth Analysis, By Type(Retinoids, Antibiotics, Isotretinoin, Others), By Route of Administration(Oral, Topical), By Age Group(10 to 17, 18 to 44, 45 to 64, 65 Above), By Distribution Channel(Hospital Pharmacies, Retail & Online Pharmacies), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2040 | Region: Global | Published Date: July, 2001
Pages: 165 | Tables: 117 | Figures: 77

Acne Treatment Market News

  • In January 2022, GALDERMA stated that it has received antitrust clearance from US authorities following the completion of its purchase of ALASTIN Skincare, Inc. for the development of novel and clinically tested physician-dispensed skincare products.
  • In January 2021, GlaxoSmithKline plc announced a collaboration with Eligo BioScience to develop Eligobiotics for the treatment and prevention of Acne Vulgaris using CRISPR-based therapies for strain-specific microbiome modification.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Acne Treatment Market size was valued at USD 9.164 billion in 2019 and is poised to grow from USD 9.6 billion in 2023 to USD 13.2 billion by 2031, growing at a CAGR of 4.63% in the forecast period (2024-2031).

The market is characterized by a high number of prominent firms that provide a wide range of medications. The significant corporations will have a solid revenue position as well as a diverse medicinal product portfolio. These firms have a strong foothold in key growth areas. The competitive environment also includes enterprises of a lesser scale with restricted product offers. 'Nestle Skin Health', 'Johnson & Johnson', 'Allergan', 'Galderma', 'Stiefel Laboratories', 'Valeant Pharmaceuticals', 'GlaxoSmithKline', 'Bayer AG', 'Teva Pharmaceuticals', 'Pfizer', 'L'Oreal S.A.', 'Proactiv Solutions', 'Beiersdorf AG', 'Unilever', 'Rohto Pharmaceutical Co. Ltd.', 'Guthy-Renker LLC', 'Murad Inc.', 'Kao Corporation', 'BioPharmX Corporation', 'Dermira Inc.'

Skin disorders are becoming more common all around the world. As a result, the number of patients choosing the treatment is fast expanding in North America, Europe, and the Asia Pacific. The advent of numerous acne therapy medications, such as retinoids, isotretinoin, and antibiotics in oral and topical forms is raising knowledge of acne products and available treatment alternatives. As a result, rising patient awareness is expected to drive market expansion.

Minimally Invasive Therapies on the go: Globally, the demand for minimally invasive cosmetic treatment methods are skyrocketing. Dermatologists prefer to treat skin problems with topical agents or less invasive techniques rather than surgery. More educated decision-making, improved patient-physician interactions, and well-documented procedures are driving up demand for treatments for face and skin disorders. This has prompted the use of less painful cosmetic combination treatment methods.

In 2022, North America accounted for USD 4.80 billion. The region’s dominance is due to the increasing frequency of acne throughout the region, as well as rising population concerns about appearance. As a result, big firms are launching new medications in the North American market. Europe will be the second leading market in terms of market size. Presence of well-established companies with a large consumer base is expected to enable more growth opportunities for the European market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Acne Treatment Market

Report ID: SQMIG35B2040

$5,300
BUY NOW GET FREE SAMPLE